Springer Nature AG (SPG) Fair Value & Analysis
Communication Services · DE · Market cap €3.9B
Fair value as of: Aug 13, 2026
From 25 valuation models · updated today
Share price +11.0% over the past month.
A solid business, screening 53% undervalued on our models.
What matters now
- The rarer combination: high quality (74/100) AND below fair value. That earns a closer look rather than a quick verdict.
- A fairly wide model range (€20.06 to €40.73) leaves room in how you read the outcome.
Price vs Fair Value (22 months)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
22‑month range €14.29 – €26.07 · fair‑value band €20.06 – €40.73 · the €19.98 price screens below the €30.50 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Springer Nature AG (SPG) currently trades at €19.98, while our model-based Fair Value estimate is €30.50, implying the stock looks roughly 52.7% undervalued today. The Quality Score stands at 74/100 (solid quality), in the Communication Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Springer Nature AG generated revenue of €1.9B at a net margin of 18.5%. Revenue grew 5.5% year over year. It earns a return on equity of 18.5%. Net debt stands at €1.2B. Fundamentals as of Aug 13, 2026
Our scenario range runs from €20.06 (bear case) to €40.73 (bull case); at €19.98, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 15% below its 52-week high and 42% above its 52-week low, currently above its 200-day average. For context, the median of 10 Communication Services peers we cover trades at 10% fair-value upside, at 53%, SPG screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 25 models by family
Widest divergence: Growth Earnings (€31.09) versus Dividend Discount (€1.62). Highest evidence: Growth DCF (80).
Notify me when SPG reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 68 · Market factors (momentum, volatility) 52
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Springer Nature AG & Co. KGaA, together with its subsidiaries, engages in the publishing business in Germany, the United Kingdom, the United States, and internationally. The company operates through three segments: Research, Education, and Health.
Full company description
Springer Nature AG & Co. KGaA, together with its subsidiaries, engages in the publishing business in Germany, the United Kingdom, the United States, and internationally. The company operates through three segments: Research, Education, and Health. It offers journals across various academic disciplines under the Nature Portfolio and Springer brand names; books in print and digital formats across various scientific disciplines, including monographs, textbooks, conference proceedings, handbook series, reference works, and briefs under the Springer and Palgrave Macmillan brand names; and support services to researchers, institutions, and industry professionals with AI-powered tools and services, such as AdisInsight, Springer Nature Experiments, protocols.io, and SpringerMaterials, as well as professional development and career services under the Nature Masterclasses, Nature Careers, and Nature Conferences brand names. The company also provides English language teaching content and national curricula learning resources under the Macmillan Education brand name. In addition, it offers specialist information and services to healthcare professionals under the Springer Medizin brand name; publications, learning solutions, and professional services to healthcare practitioners and students under the BSL brand name; content and services related to drug treatments, medical devices, and diagnostics under the Springer Health+ brand name; and Cureus Journal of Medical Science, a peer-reviewed OA medical journal. The company was founded in 1842 and is based in Berlin, Germany. Springer Nature AG & Co. KGaA operates as a subsidiary of GvH Vermögensverwaltungsgesellschaft Xxxiii mbH.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2023 – FY2025 · reported fiscal years
Springer Nature AG reported revenue of €1.9B in FY2025 versus €1.9B in FY2023, a compound +2.0%/yr. Reported net income was €356M in FY2025, compounding +379.0%/yr from FY2023.
Watch SPG: get an alert when its fair value changes →
Recent news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- Springer Nature AG & Co KGaA (SPGNY) (H1 2026) Earnings Call Highlights: Strong Growth and ...
- Springer Nature AG & Co. KGaA (ETR:SPG) Passed Our Checks, And It's About To Pay A €0.83 Dividend
- Springer Nature's CFO to Leave the Company by the end of 2026
- Springer Nature Shares Recover Some Ground on Upbeat Outlook
Peer Group
Publishing · 111 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Publishing median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Publishing stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The New York Times Company NYT | $63.95 | $41.95 | -34% |
| Jiangsu Phoenix Publishing & Media Corporation 601928 | ¥9.16 | ¥10.07 | +10% |
| China Science Publishing & Media Ltd 601858 | ¥24.46 | ¥10.31 | -58% |
| People.cn CO., LTD 603000 | ¥16.85 | ¥4.23 | -75% |
| China South Publishing & Media Group 601098 | ¥10.31 | ¥14.66 | +42% |
| John Wiley & Sons, Inc WLY | $49.94 | $55.90 | +12% |
| Zhejiang Publishing & Media Co 601921 | ¥7.15 | ¥7.54 | +5% |
| Xinhua Winshare Publishing and Media Co 601811 | ¥11.93 | ¥21.02 | +76% |
| Shandong Publishing&Media Co 601019 | ¥6.95 | ¥11.60 | +67% |
| Guangdong Guangzhou Daily Media Co 002181 | ¥9.38 | ¥1.35 | -86% |
Compare Springer Nature AG with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Communication Services stocks →
Frequently asked questions
Is Springer Nature AG (SPG) overvalued or undervalued?
What is the fair value of SPG?
What is the quality score of SPG?
What is the revenue of Springer Nature AG (SPG)?
What is the net profit margin of SPG?
Does Springer Nature AG pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Springer Nature AG and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.